New testing method could speed up personalized cancer drug discovery

Researchers compared two laboratory growth systems for testing cancer drugs against patient tumor cells, a critical step toward tailored treatment plans. The findings could help pharmaceutical companies and hospitals faster identify which drugs work best for individual patients, potentially reducing trial-and-error treatment cycles.

Originaltitel: Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)